Nisa Investment Advisors LLC Increases Stock Holdings in Axon Enterprise, Inc (NASDAQ:AXON)

Nisa Investment Advisors LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 61.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,143 shares of the biotechnology company's stock after purchasing an additional 4,622 shares during the period. Nisa Investment Advisors LLC's holdings in Axon Enterprise were worth $6,387,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Pinion Investment Advisors LLC grew its position in shares of Axon Enterprise by 3.0% in the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after purchasing an additional 19 shares during the period. Kentucky Retirement Systems grew its position in Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock valued at $2,605,000 after acquiring an additional 19 shares during the period. WCM Investment Management LLC grew its position in Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after acquiring an additional 19 shares during the period. HBK Sorce Advisory LLC grew its position in Axon Enterprise by 4.6% during the first quarter. HBK Sorce Advisory LLC now owns 451 shares of the biotechnology company's stock valued at $237,000 after acquiring an additional 20 shares during the period. Finally, Beacon Pointe Advisors LLC grew its position in Axon Enterprise by 2.6% during the fourth quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company's stock valued at $513,000 after acquiring an additional 22 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 9,905 shares of the company's stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the sale, the president owned 298,809 shares in the company, valued at $220,530,006.27. This represents a 3.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Brittany Bagley sold 3,400 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total value of $2,380,000.00. Following the sale, the chief financial officer owned 131,833 shares in the company, valued at $92,283,100. The trade was a 2.51% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 44,642 shares of company stock valued at $30,500,428. Insiders own 4.40% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on AXON shares. Wolfe Research started coverage on Axon Enterprise in a research report on Monday. They set an "outperform" rating for the company. The Goldman Sachs Group boosted their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Bank of America boosted their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Barclays boosted their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, Needham & Company LLC boosted their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat, Axon Enterprise has an average rating of "Moderate Buy" and an average price target of $699.55.

Axon Enterprise Stock Down 0.5%

Shares of NASDAQ:AXON opened at $729.62 on Friday. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 52-week low of $279.02 and a 52-week high of $830.21. The company has a 50 day moving average of $752.67 and a two-hundred day moving average of $640.95. The company has a market capitalization of $56.80 billion, a price-to-earnings ratio of 176.24, a price-to-earnings-growth ratio of 84.37 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The business had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. During the same quarter in the previous year, the firm posted $1.15 earnings per share. The company's revenue was up 31.3% compared to the same quarter last year. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.